RB1 and TP53 mutations, PI3K/AKT family activation and NOTCH signaling downregulation, MYC and SOX families, and AKT pathway activation are all involved in SCLC transformation (Yin et al., 2022). Here, AKT1 is linked to small cell lung carcinoma.